DEUTSCHE BANK AG\ - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314507. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q4 2019$35,000183,757
+36651.4%
0.00%
Q1 2019$05000.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q2 2019
NameSharesValueWeighting ↓
Cornerstone Wealth Management, LLC 35,000$8,0000.00%
ROYAL BANK OF CANADA 5$00.00%
VANGUARD GROUP INC 1,150,903$268,0000.00%
UBS Group AG 75,301$18,0000.00%
Sowell Financial Services LLC 562$00.00%
BNP PARIBAS FINANCIAL MARKETS 1$00.00%
OSAIC HOLDINGS, INC. 385$00.00%
BANK OF AMERICA CORP /DE/ 6,125$1,0000.00%
FLAGSHIP HARBOR ADVISORS, LLC 375$00.00%
WELLS FARGO & COMPANY/MN 556$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders